The immunomodulatory effect of inhaled granulocyte-macrophage colony-stimulating factor in cystic fibrosis. A new treatment paradigm

Keyphrases

• Cystic Fibrosis 100%
• Granulocyte Colony-stimulating Factor (G-CSF) 100%
• Treatment Paradigms 100%
• Immunomodulatory Effect 100%
• T Helper 2 66%
• T Helper 1 33%
• Poor Prognosis 33%
• Lung 33%
• T Cell Activation 33%
• Chronic Infection 33%
• Alveolar Inflammation 33%
• Pulmonary Dysfunction 33%
• CD20 33%
• Recurrent Infection 33%
• Alveolar Macrophages 33%
• Long Sequence 33%
• Macrophage Dysfunction 33%
• Complex Events 33%

Medicine and Dentistry

• Cystic Fibrosis 100%
• Granulocyte Macrophage Colony Stimulating Factor 100%
• Infection 50%
• T Cell Activation 50%
• Patient with Cystic Fibrosis 50%
• CD20 50%
• Recurrent Infection 50%
• Alveolar Macrophage 50%